BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A. has sponsored the creation of one or more 401k plans.
| Measure | Date | Value |
|---|
| 2023 : US SCIENTIFIC ALPHA FUND B 2023 401k financial data |
|---|
| Unrealized appreciation/depreciation of other (non real estate) assets | 2023-12-31 | $-1,397,208 |
| Total unrealized appreciation/depreciation of assets | 2023-12-31 | $-1,397,208 |
| Total transfer of assets from this plan | 2023-12-31 | $26,710,300 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-12-31 | $127,430,442 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-12-31 | $161,451,786 |
| Total income from all sources (including contributions) | 2023-12-31 | $11,676,884 |
| Total loss/gain on sale of assets | 2023-12-31 | $7,801,915 |
| Total of all expenses incurred | 2023-12-31 | $527,062 |
| Value of total assets at end of year | 2023-12-31 | $238,745,818 |
| Value of total assets at beginning of year | 2023-12-31 | $288,327,640 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2023-12-31 | $527,062 |
| Total interest from all sources | 2023-12-31 | $5,862,074 |
| Total dividends received (eg from common stock, registered investment company shares) | 2023-12-31 | $2,623,542 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2023-12-31 | No |
| Assets. Corporate prefeered stocks other than exployer securities at end of year | 2023-12-31 | $1,402 |
| Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2023-12-31 | $1,336 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2023-12-31 | $711,100 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2023-12-31 | $7,682,598 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2023-12-31 | $127,430,442 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2023-12-31 | $161,451,786 |
| Other income not declared elsewhere | 2023-12-31 | $-3,213,439 |
| Administrative expenses (other) incurred | 2023-12-31 | $435,844 |
| Total non interest bearing cash at end of year | 2023-12-31 | $105,059,318 |
| Total non interest bearing cash at beginning of year | 2023-12-31 | $104,067,199 |
| Value of net income/loss | 2023-12-31 | $11,149,822 |
| Value of net assets at end of year (total assets less liabilities) | 2023-12-31 | $111,315,376 |
| Value of net assets at beginning of year (total assets less liabilities) | 2023-12-31 | $126,875,854 |
| Investment advisory and management fees | 2023-12-31 | $71,493 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2023-12-31 | $6,012,432 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2023-12-31 | $22,416,952 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2023-12-31 | $22,416,952 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2023-12-31 | $5,862,074 |
| Income. Dividends from common stock | 2023-12-31 | $2,623,542 |
| Assets. Corporate common stocks other than exployer securities at end of year | 2023-12-31 | $126,961,566 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2023-12-31 | $154,159,555 |
| Aggregate proceeds on sale of assets | 2023-12-31 | $934,340,222 |
| Aggregate carrying amount (costs) on sale of assets | 2023-12-31 | $926,538,307 |
| Unrealized appreciation/depreciation of other (non real estate) assets | 2023-01-01 | $-1,397,208 |
| Total unrealized appreciation/depreciation of assets | 2023-01-01 | $-1,397,208 |
| Total transfer of assets from this plan | 2023-01-01 | $26,710,300 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-01-01 | $127,430,442 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-01-01 | $161,451,786 |
| Total income from all sources (including contributions) | 2023-01-01 | $11,676,884 |
| Total loss/gain on sale of assets | 2023-01-01 | $7,801,915 |
| Total of all expenses incurred | 2023-01-01 | $527,062 |
| Value of total assets at end of year | 2023-01-01 | $238,745,818 |
| Value of total assets at beginning of year | 2023-01-01 | $288,327,640 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2023-01-01 | $527,062 |
| Total interest from all sources | 2023-01-01 | $5,862,074 |
| Total dividends received (eg from common stock, registered investment company shares) | 2023-01-01 | $2,623,542 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2023-01-01 | No |
| Assets. Corporate prefeered stocks other than exployer securities at end of year | 2023-01-01 | $1,402 |
| Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2023-01-01 | $1,336 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2023-01-01 | $711,100 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2023-01-01 | $7,682,598 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2023-01-01 | $127,430,442 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2023-01-01 | $161,451,786 |
| Other income not declared elsewhere | 2023-01-01 | $-3,213,439 |
| Administrative expenses (other) incurred | 2023-01-01 | $435,844 |
| Total non interest bearing cash at end of year | 2023-01-01 | $105,059,318 |
| Total non interest bearing cash at beginning of year | 2023-01-01 | $104,067,199 |
| Value of net income/loss | 2023-01-01 | $11,149,822 |
| Value of net assets at end of year (total assets less liabilities) | 2023-01-01 | $111,315,376 |
| Value of net assets at beginning of year (total assets less liabilities) | 2023-01-01 | $126,875,854 |
| Investment advisory and management fees | 2023-01-01 | $71,493 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2023-01-01 | $6,012,432 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2023-01-01 | $5,862,074 |
| Income. Dividends from common stock | 2023-01-01 | $2,623,542 |
| Assets. Corporate common stocks other than exployer securities at end of year | 2023-01-01 | $126,961,566 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2023-01-01 | $154,159,555 |
| Aggregate proceeds on sale of assets | 2023-01-01 | $934,340,222 |
| Aggregate carrying amount (costs) on sale of assets | 2023-01-01 | $926,538,307 |
| 2022 : US SCIENTIFIC ALPHA FUND B 2022 401k financial data |
|---|
| Unrealized appreciation/depreciation of other (non real estate) assets | 2022-12-31 | $-557,262 |
| Total unrealized appreciation/depreciation of assets | 2022-12-31 | $-557,262 |
| Total transfer of assets from this plan | 2022-12-31 | $16,500,150 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $161,451,786 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $178,039,587 |
| Total income from all sources (including contributions) | 2022-12-31 | $9,959,545 |
| Total loss/gain on sale of assets | 2022-12-31 | $9,237,842 |
| Total of all expenses incurred | 2022-12-31 | $655,709 |
| Value of total assets at end of year | 2022-12-31 | $288,327,640 |
| Value of total assets at beginning of year | 2022-12-31 | $312,111,755 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-12-31 | $655,709 |
| Total interest from all sources | 2022-12-31 | $2,009,192 |
| Total dividends received (eg from common stock, registered investment company shares) | 2022-12-31 | $2,962,371 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2022-12-31 | No |
| Administrative expenses professional fees incurred | 2022-12-31 | $19,356 |
| Assets. Corporate prefeered stocks other than exployer securities at end of year | 2022-12-31 | $1,336 |
| Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2022-12-31 | $4,026 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2022-12-31 | $7,682,598 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2022-12-31 | $2,949,464 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2022-12-31 | $161,451,786 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2022-12-31 | $178,039,587 |
| Other income not declared elsewhere | 2022-12-31 | $-3,692,598 |
| Administrative expenses (other) incurred | 2022-12-31 | $530,602 |
| Total non interest bearing cash at end of year | 2022-12-31 | $104,067,199 |
| Total non interest bearing cash at beginning of year | 2022-12-31 | $70,072,878 |
| Value of net income/loss | 2022-12-31 | $9,303,836 |
| Value of net assets at end of year (total assets less liabilities) | 2022-12-31 | $126,875,854 |
| Value of net assets at beginning of year (total assets less liabilities) | 2022-12-31 | $134,072,168 |
| Investment advisory and management fees | 2022-12-31 | $105,751 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2022-12-31 | $22,416,952 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2022-12-31 | $64,248,140 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2022-12-31 | $64,248,140 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2022-12-31 | $2,009,192 |
| Income. Dividends from common stock | 2022-12-31 | $2,962,371 |
| Assets. Corporate common stocks other than exployer securities at end of year | 2022-12-31 | $154,159,555 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2022-12-31 | $174,837,247 |
| Aggregate proceeds on sale of assets | 2022-12-31 | $1,088,592,276 |
| Aggregate carrying amount (costs) on sale of assets | 2022-12-31 | $1,079,354,434 |
| Unrealized appreciation/depreciation of other (non real estate) assets | 2022-01-01 | $-557,262 |
| Total unrealized appreciation/depreciation of assets | 2022-01-01 | $-557,262 |
| Total transfer of assets from this plan | 2022-01-01 | $16,500,150 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-01-01 | $161,451,786 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-01-01 | $178,039,587 |
| Total income from all sources (including contributions) | 2022-01-01 | $9,959,545 |
| Total loss/gain on sale of assets | 2022-01-01 | $9,237,842 |
| Total of all expenses incurred | 2022-01-01 | $655,709 |
| Value of total assets at end of year | 2022-01-01 | $288,327,640 |
| Value of total assets at beginning of year | 2022-01-01 | $312,111,755 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-01-01 | $655,709 |
| Total interest from all sources | 2022-01-01 | $2,009,192 |
| Total dividends received (eg from common stock, registered investment company shares) | 2022-01-01 | $2,962,371 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2022-01-01 | No |
| Administrative expenses professional fees incurred | 2022-01-01 | $19,356 |
| Assets. Corporate prefeered stocks other than exployer securities at end of year | 2022-01-01 | $1,336 |
| Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2022-01-01 | $4,026 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2022-01-01 | $7,682,598 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2022-01-01 | $2,949,464 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2022-01-01 | $161,451,786 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2022-01-01 | $178,039,587 |
| Other income not declared elsewhere | 2022-01-01 | $-3,692,598 |
| Administrative expenses (other) incurred | 2022-01-01 | $530,602 |
| Total non interest bearing cash at end of year | 2022-01-01 | $104,067,199 |
| Total non interest bearing cash at beginning of year | 2022-01-01 | $70,072,878 |
| Value of net income/loss | 2022-01-01 | $9,303,836 |
| Value of net assets at end of year (total assets less liabilities) | 2022-01-01 | $126,875,854 |
| Value of net assets at beginning of year (total assets less liabilities) | 2022-01-01 | $134,072,168 |
| Investment advisory and management fees | 2022-01-01 | $105,751 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2022-01-01 | $22,416,952 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2022-01-01 | $2,009,192 |
| Income. Dividends from common stock | 2022-01-01 | $2,962,371 |
| Assets. Corporate common stocks other than exployer securities at end of year | 2022-01-01 | $154,159,555 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2022-01-01 | $174,837,247 |
| Aggregate proceeds on sale of assets | 2022-01-01 | $1,088,592,276 |
| Aggregate carrying amount (costs) on sale of assets | 2022-01-01 | $1,079,354,434 |
| 2021 : US SCIENTIFIC ALPHA FUND B 2021 401k financial data |
|---|
| Unrealized appreciation/depreciation of other (non real estate) assets | 2021-12-31 | $5,486,447 |
| Total unrealized appreciation/depreciation of assets | 2021-12-31 | $5,486,447 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $178,039,587 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $178,838,644 |
| Expenses. Interest paid | 2021-12-31 | $4,825 |
| Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102 | 2021-12-31 | $4,825 |
| Total income from all sources (including contributions) | 2021-12-31 | $8,451,990 |
| Total loss/gain on sale of assets | 2021-12-31 | $3,231,797 |
| Total of all expenses incurred | 2021-12-31 | $712,033 |
| Value of total assets at end of year | 2021-12-31 | $312,111,755 |
| Value of total assets at beginning of year | 2021-12-31 | $305,170,855 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2021-12-31 | $707,208 |
| Total interest from all sources | 2021-12-31 | $133,986 |
| Total dividends received (eg from common stock, registered investment company shares) | 2021-12-31 | $2,661,408 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2021-12-31 | No |
| Administrative expenses professional fees incurred | 2021-12-31 | $17,174 |
| Assets. Corporate prefeered stocks other than exployer securities at end of year | 2021-12-31 | $4,026 |
| Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2021-12-31 | $3,861 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2021-12-31 | $2,949,464 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2021-12-31 | $5,286,657 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2021-12-31 | $178,039,587 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2021-12-31 | $178,838,644 |
| Other income not declared elsewhere | 2021-12-31 | $-3,061,648 |
| Administrative expenses (other) incurred | 2021-12-31 | $584,445 |
| Total non interest bearing cash at end of year | 2021-12-31 | $70,072,878 |
| Total non interest bearing cash at beginning of year | 2021-12-31 | $66,236,918 |
| Value of net income/loss | 2021-12-31 | $7,739,957 |
| Value of net assets at end of year (total assets less liabilities) | 2021-12-31 | $134,072,168 |
| Value of net assets at beginning of year (total assets less liabilities) | 2021-12-31 | $126,332,211 |
| Investment advisory and management fees | 2021-12-31 | $105,589 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2021-12-31 | $64,248,140 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2021-12-31 | $60,217,868 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2021-12-31 | $60,217,868 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2021-12-31 | $133,986 |
| Income. Dividends from common stock | 2021-12-31 | $2,661,408 |
| Assets. Corporate common stocks other than exployer securities at end of year | 2021-12-31 | $174,837,247 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2021-12-31 | $173,425,551 |
| Aggregate proceeds on sale of assets | 2021-12-31 | $1,297,985,404 |
| Aggregate carrying amount (costs) on sale of assets | 2021-12-31 | $1,294,753,607 |
| 2020 : US SCIENTIFIC ALPHA FUND B 2020 401k financial data |
|---|
| Unrealized appreciation/depreciation of other (non real estate) assets | 2020-12-31 | $-4,302,764 |
| Total unrealized appreciation/depreciation of assets | 2020-12-31 | $-4,302,764 |
| Total transfer of assets from this plan | 2020-12-31 | $7,500,000 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $178,838,644 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $183,939,250 |
| Expenses. Interest paid | 2020-12-31 | $72 |
| Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102 | 2020-12-31 | $72 |
| Total income from all sources (including contributions) | 2020-12-31 | $5,787,130 |
| Total loss/gain on sale of assets | 2020-12-31 | $9,648,720 |
| Total of all expenses incurred | 2020-12-31 | $724,748 |
| Value of total assets at end of year | 2020-12-31 | $305,170,855 |
| Value of total assets at beginning of year | 2020-12-31 | $312,709,079 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2020-12-31 | $724,676 |
| Total interest from all sources | 2020-12-31 | $637,652 |
| Total dividends received (eg from common stock, registered investment company shares) | 2020-12-31 | $3,178,254 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2020-12-31 | No |
| Administrative expenses professional fees incurred | 2020-12-31 | $17,280 |
| Assets. Corporate prefeered stocks other than exployer securities at end of year | 2020-12-31 | $3,861 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2020-12-31 | $5,286,657 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2020-12-31 | $3,636,166 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2020-12-31 | $178,838,644 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2020-12-31 | $183,939,250 |
| Other income not declared elsewhere | 2020-12-31 | $-3,374,732 |
| Administrative expenses (other) incurred | 2020-12-31 | $614,964 |
| Total non interest bearing cash at end of year | 2020-12-31 | $66,236,918 |
| Total non interest bearing cash at beginning of year | 2020-12-31 | $61,290,497 |
| Value of net income/loss | 2020-12-31 | $5,062,382 |
| Value of net assets at end of year (total assets less liabilities) | 2020-12-31 | $126,332,211 |
| Value of net assets at beginning of year (total assets less liabilities) | 2020-12-31 | $128,769,829 |
| Investment advisory and management fees | 2020-12-31 | $92,432 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2020-12-31 | $60,217,868 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2020-12-31 | $67,236,702 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2020-12-31 | $67,236,702 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2020-12-31 | $637,652 |
| Income. Dividends from common stock | 2020-12-31 | $3,178,254 |
| Assets. Corporate common stocks other than exployer securities at end of year | 2020-12-31 | $173,425,551 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2020-12-31 | $180,545,714 |
| Aggregate proceeds on sale of assets | 2020-12-31 | $1,339,405,954 |
| Aggregate carrying amount (costs) on sale of assets | 2020-12-31 | $1,329,757,234 |
| 2019 : US SCIENTIFIC ALPHA FUND B 2019 401k financial data |
|---|
| Unrealized appreciation/depreciation of other (non real estate) assets | 2019-12-31 | $1,140,559 |
| Total unrealized appreciation/depreciation of assets | 2019-12-31 | $1,140,559 |
| Total transfer of assets to this plan | 2019-12-31 | $24,169,210 |
| Total transfer of assets from this plan | 2019-12-31 | $4,000,150 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $183,939,250 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $149,622,902 |
| Total income from all sources (including contributions) | 2019-12-31 | $12,332,331 |
| Total loss/gain on sale of assets | 2019-12-31 | $9,026,821 |
| Total of all expenses incurred | 2019-12-31 | $572,696 |
| Value of total assets at end of year | 2019-12-31 | $312,709,079 |
| Value of total assets at beginning of year | 2019-12-31 | $246,464,036 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2019-12-31 | $572,696 |
| Total interest from all sources | 2019-12-31 | $2,300,123 |
| Total dividends received (eg from common stock, registered investment company shares) | 2019-12-31 | $2,981,161 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2019-12-31 | No |
| Administrative expenses professional fees incurred | 2019-12-31 | $20,728 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2019-12-31 | $3,636,166 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2019-12-31 | $59,157,413 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2019-12-31 | $183,939,250 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2019-12-31 | $149,622,902 |
| Other income not declared elsewhere | 2019-12-31 | $-3,116,333 |
| Administrative expenses (other) incurred | 2019-12-31 | $530,812 |
| Total non interest bearing cash at end of year | 2019-12-31 | $61,290,497 |
| Total non interest bearing cash at beginning of year | 2019-12-31 | $0 |
| Value of net income/loss | 2019-12-31 | $11,759,635 |
| Value of net assets at end of year (total assets less liabilities) | 2019-12-31 | $128,769,829 |
| Value of net assets at beginning of year (total assets less liabilities) | 2019-12-31 | $96,841,134 |
| Investment advisory and management fees | 2019-12-31 | $21,156 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2019-12-31 | $67,236,702 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2019-12-31 | $45,923,983 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2019-12-31 | $45,923,983 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2019-12-31 | $2,300,123 |
| Income. Dividends from common stock | 2019-12-31 | $2,981,161 |
| Assets. Corporate common stocks other than exployer securities at end of year | 2019-12-31 | $180,545,714 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2019-12-31 | $141,382,640 |
| Aggregate proceeds on sale of assets | 2019-12-31 | $1,063,896,448 |
| Aggregate carrying amount (costs) on sale of assets | 2019-12-31 | $1,054,869,627 |
| 2018 : US SCIENTIFIC ALPHA FUND B 2018 401k financial data |
|---|
| Unrealized appreciation/depreciation of other (non real estate) assets | 2018-12-31 | $1,360,952 |
| Total unrealized appreciation/depreciation of assets | 2018-12-31 | $1,360,952 |
| Total transfer of assets to this plan | 2018-12-31 | $21,699,550 |
| Total transfer of assets from this plan | 2018-12-31 | $24,000,150 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2018-12-31 | $149,622,902 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2018-12-31 | $172,925,212 |
| Expenses. Interest paid | 2018-12-31 | $65 |
| Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102 | 2018-12-31 | $65 |
| Total income from all sources (including contributions) | 2018-12-31 | $4,744,743 |
| Total loss/gain on sale of assets | 2018-12-31 | $1,334,979 |
| Total of all expenses incurred | 2018-12-31 | $788,480 |
| Value of total assets at end of year | 2018-12-31 | $246,464,036 |
| Value of total assets at beginning of year | 2018-12-31 | $268,110,683 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2018-12-31 | $788,415 |
| Total interest from all sources | 2018-12-31 | $1,917,244 |
| Total dividends received (eg from common stock, registered investment company shares) | 2018-12-31 | $3,015,767 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2018-12-31 | No |
| Administrative expenses professional fees incurred | 2018-12-31 | $21,049 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2018-12-31 | $59,157,413 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2018-12-31 | $58,784,131 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2018-12-31 | $149,622,902 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2018-12-31 | $172,925,212 |
| Other income not declared elsewhere | 2018-12-31 | $-2,884,199 |
| Administrative expenses (other) incurred | 2018-12-31 | $700,323 |
| Value of net income/loss | 2018-12-31 | $3,956,263 |
| Value of net assets at end of year (total assets less liabilities) | 2018-12-31 | $96,841,134 |
| Value of net assets at beginning of year (total assets less liabilities) | 2018-12-31 | $95,185,471 |
| Investment advisory and management fees | 2018-12-31 | $67,043 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2018-12-31 | $45,923,983 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2018-12-31 | $47,132,782 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2018-12-31 | $47,132,782 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2018-12-31 | $1,917,244 |
| Income. Dividends from common stock | 2018-12-31 | $3,015,767 |
| Assets. Corporate common stocks other than exployer securities at end of year | 2018-12-31 | $141,382,640 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2018-12-31 | $162,193,770 |
| Aggregate proceeds on sale of assets | 2018-12-31 | $1,353,346,054 |
| Aggregate carrying amount (costs) on sale of assets | 2018-12-31 | $1,352,011,075 |
| 2017 : US SCIENTIFIC ALPHA FUND B 2017 401k financial data |
|---|
| Unrealized appreciation/depreciation of other (non real estate) assets | 2017-12-31 | $671,652 |
| Total unrealized appreciation/depreciation of assets | 2017-12-31 | $671,652 |
| Total transfer of assets to this plan | 2017-12-31 | $13,750,000 |
| Total transfer of assets from this plan | 2017-12-31 | $12,000,150 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2017-12-31 | $172,925,212 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2017-12-31 | $165,349,262 |
| Expenses. Interest paid | 2017-12-31 | $1 |
| Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102 | 2017-12-31 | $1 |
| Total income from all sources (including contributions) | 2017-12-31 | $4,325,057 |
| Total loss/gain on sale of assets | 2017-12-31 | $2,921,602 |
| Total of all expenses incurred | 2017-12-31 | $802,855 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2017-12-31 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2017-12-31 | $0 |
| Value of total assets at end of year | 2017-12-31 | $268,110,683 |
| Value of total assets at beginning of year | 2017-12-31 | $255,262,681 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2017-12-31 | $802,854 |
| Total interest from all sources | 2017-12-31 | $904,924 |
| Total dividends received (eg from common stock, registered investment company shares) | 2017-12-31 | $3,014,919 |
| Administrative expenses professional fees incurred | 2017-12-31 | $20,967 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2017-12-31 | $58,784,131 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2017-12-31 | $60,147,692 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2017-12-31 | $172,925,212 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2017-12-31 | $165,349,262 |
| Other income not declared elsewhere | 2017-12-31 | $-3,188,040 |
| Administrative expenses (other) incurred | 2017-12-31 | $688,720 |
| Value of net income/loss | 2017-12-31 | $3,522,202 |
| Value of net assets at end of year (total assets less liabilities) | 2017-12-31 | $95,185,471 |
| Value of net assets at beginning of year (total assets less liabilities) | 2017-12-31 | $89,913,419 |
| Investment advisory and management fees | 2017-12-31 | $93,167 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2017-12-31 | $47,132,782 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2017-12-31 | $42,800,999 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2017-12-31 | $42,800,999 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2017-12-31 | $904,924 |
| Income. Dividends from common stock | 2017-12-31 | $3,014,919 |
| Assets. Corporate common stocks other than exployer securities at end of year | 2017-12-31 | $162,193,770 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2017-12-31 | $152,313,990 |
| Aggregate proceeds on sale of assets | 2017-12-31 | $1,533,845,989 |
| Aggregate carrying amount (costs) on sale of assets | 2017-12-31 | $1,530,924,387 |
| 2016 : US SCIENTIFIC ALPHA FUND B 2016 401k financial data |
|---|
| Unrealized appreciation/depreciation of other (non real estate) assets | 2016-12-31 | $1,621,058 |
| Total unrealized appreciation/depreciation of assets | 2016-12-31 | $1,621,058 |
| Total transfer of assets to this plan | 2016-12-31 | $0 |
| Total transfer of assets from this plan | 2016-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2016-12-31 | $165,349,262 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2016-12-31 | $166,707,067 |
| Total income from all sources (including contributions) | 2016-12-31 | $3,368,032 |
| Total loss/gain on sale of assets | 2016-12-31 | $1,212,305 |
| Total of all expenses incurred | 2016-12-31 | $815,610 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2016-12-31 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2016-12-31 | $0 |
| Value of total assets at end of year | 2016-12-31 | $255,262,681 |
| Value of total assets at beginning of year | 2016-12-31 | $254,068,064 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2016-12-31 | $815,610 |
| Total interest from all sources | 2016-12-31 | $307,351 |
| Total dividends received (eg from common stock, registered investment company shares) | 2016-12-31 | $2,980,171 |
| Administrative expenses professional fees incurred | 2016-12-31 | $21,510 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2016-12-31 | $60,147,692 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2016-12-31 | $88,545,928 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2016-12-31 | $165,349,262 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2016-12-31 | $166,707,067 |
| Other income not declared elsewhere | 2016-12-31 | $-2,752,853 |
| Administrative expenses (other) incurred | 2016-12-31 | $700,728 |
| Value of net income/loss | 2016-12-31 | $2,552,422 |
| Value of net assets at end of year (total assets less liabilities) | 2016-12-31 | $89,913,419 |
| Value of net assets at beginning of year (total assets less liabilities) | 2016-12-31 | $87,360,997 |
| Investment advisory and management fees | 2016-12-31 | $93,372 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2016-12-31 | $42,800,999 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2016-12-31 | $15,083,197 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2016-12-31 | $15,083,197 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2016-12-31 | $307,351 |
| Income. Dividends from common stock | 2016-12-31 | $2,980,171 |
| Assets. Corporate common stocks other than exployer securities at end of year | 2016-12-31 | $152,313,990 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2016-12-31 | $150,438,939 |
| Aggregate proceeds on sale of assets | 2016-12-31 | $1,805,262,574 |
| Aggregate carrying amount (costs) on sale of assets | 2016-12-31 | $1,804,050,269 |
| 2015 : US SCIENTIFIC ALPHA FUND B 2015 401k financial data |
|---|
| Unrealized appreciation/depreciation of other (non real estate) assets | 2015-12-31 | $-590,824 |
| Total unrealized appreciation/depreciation of assets | 2015-12-31 | $-590,824 |
| Total transfer of assets to this plan | 2015-12-31 | $5,700,000 |
| Total transfer of assets from this plan | 2015-12-31 | $23,000,200 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2015-12-31 | $166,707,067 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2015-12-31 | $201,858,454 |
| Expenses. Interest paid | 2015-12-31 | $221,805 |
| Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102 | 2015-12-31 | $221,805 |
| Total income from all sources (including contributions) | 2015-12-31 | $15,050,061 |
| Total loss/gain on sale of assets | 2015-12-31 | $14,959,902 |
| Total of all expenses incurred | 2015-12-31 | $1,491,077 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2015-12-31 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2015-12-31 | $0 |
| Value of total assets at end of year | 2015-12-31 | $254,068,064 |
| Value of total assets at beginning of year | 2015-12-31 | $292,960,667 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2015-12-31 | $1,269,272 |
| Total interest from all sources | 2015-12-31 | $64,930 |
| Total dividends received (eg from common stock, registered investment company shares) | 2015-12-31 | $3,217,544 |
| Administrative expenses professional fees incurred | 2015-12-31 | $21,510 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2015-12-31 | $88,545,928 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2015-12-31 | $20,250,652 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2015-12-31 | $166,707,067 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2015-12-31 | $201,858,454 |
| Other income not declared elsewhere | 2015-12-31 | $-2,601,491 |
| Administrative expenses (other) incurred | 2015-12-31 | $1,168,288 |
| Value of net income/loss | 2015-12-31 | $13,558,984 |
| Value of net assets at end of year (total assets less liabilities) | 2015-12-31 | $87,360,997 |
| Value of net assets at beginning of year (total assets less liabilities) | 2015-12-31 | $91,102,213 |
| Investment advisory and management fees | 2015-12-31 | $79,474 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2015-12-31 | $15,083,197 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2015-12-31 | $89,881,116 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2015-12-31 | $89,881,116 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2015-12-31 | $64,930 |
| Income. Dividends from common stock | 2015-12-31 | $3,217,544 |
| Assets. Corporate common stocks other than exployer securities at end of year | 2015-12-31 | $150,438,939 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2015-12-31 | $182,828,899 |
| Aggregate proceeds on sale of assets | 2015-12-31 | $2,096,047,021 |
| Aggregate carrying amount (costs) on sale of assets | 2015-12-31 | $2,081,087,119 |
| 2014 : US SCIENTIFIC ALPHA FUND B 2014 401k financial data |
|---|
| Unrealized appreciation/depreciation of other (non real estate) assets | 2014-12-31 | $-55,132 |
| Total unrealized appreciation/depreciation of assets | 2014-12-31 | $-55,132 |
| Total transfer of assets to this plan | 2014-12-31 | $9,999,825 |
| Total transfer of assets from this plan | 2014-12-31 | $5,000,150 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2014-12-31 | $201,858,454 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2014-12-31 | $221,251,023 |
| Expenses. Interest paid | 2014-12-31 | $249,221 |
| Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102 | 2014-12-31 | $249,221 |
| Total income from all sources (including contributions) | 2014-12-31 | $6,917,071 |
| Total loss/gain on sale of assets | 2014-12-31 | $6,512,542 |
| Total of all expenses incurred | 2014-12-31 | $1,586,832 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2014-12-31 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2014-12-31 | $0 |
| Value of total assets at end of year | 2014-12-31 | $292,960,667 |
| Value of total assets at beginning of year | 2014-12-31 | $302,023,322 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2014-12-31 | $1,337,611 |
| Total interest from all sources | 2014-12-31 | $0 |
| Total dividends received (eg from common stock, registered investment company shares) | 2014-12-31 | $3,031,883 |
| Administrative expenses professional fees incurred | 2014-12-31 | $21,230 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2014-12-31 | $20,250,652 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2014-12-31 | $45,600,422 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2014-12-31 | $201,858,454 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2014-12-31 | $221,251,023 |
| Other income not declared elsewhere | 2014-12-31 | $-2,572,222 |
| Administrative expenses (other) incurred | 2014-12-31 | $1,245,616 |
| Value of net income/loss | 2014-12-31 | $5,330,239 |
| Value of net assets at end of year (total assets less liabilities) | 2014-12-31 | $91,102,213 |
| Value of net assets at beginning of year (total assets less liabilities) | 2014-12-31 | $80,772,299 |
| Investment advisory and management fees | 2014-12-31 | $70,765 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2014-12-31 | $89,881,116 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2014-12-31 | $81,799,077 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2014-12-31 | $81,799,077 |
| Income. Dividends from common stock | 2014-12-31 | $3,031,883 |
| Assets. Corporate common stocks other than exployer securities at end of year | 2014-12-31 | $182,828,899 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2014-12-31 | $174,623,823 |
| Aggregate proceeds on sale of assets | 2014-12-31 | $2,750,969,036 |
| Aggregate carrying amount (costs) on sale of assets | 2014-12-31 | $2,744,456,494 |
| 2013 : US SCIENTIFIC ALPHA FUND B 2013 401k financial data |
|---|
| Unrealized appreciation/depreciation of other (non real estate) assets | 2013-12-31 | $3,198,230 |
| Total unrealized appreciation/depreciation of assets | 2013-12-31 | $3,198,230 |
| Total transfer of assets to this plan | 2013-12-31 | $0 |
| Total transfer of assets from this plan | 2013-12-31 | $10,000,275 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2013-12-31 | $221,251,023 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2013-12-31 | $197,204,053 |
| Expenses. Interest paid | 2013-12-31 | $239,743 |
| Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102 | 2013-12-31 | $239,743 |
| Total income from all sources (including contributions) | 2013-12-31 | $-3,881,207 |
| Total loss/gain on sale of assets | 2013-12-31 | $-7,887,931 |
| Total of all expenses incurred | 2013-12-31 | $2,248,358 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2013-12-31 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2013-12-31 | $0 |
| Value of total assets at end of year | 2013-12-31 | $302,023,322 |
| Value of total assets at beginning of year | 2013-12-31 | $294,106,192 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2013-12-31 | $2,008,615 |
| Total interest from all sources | 2013-12-31 | $0 |
| Total dividends received (eg from common stock, registered investment company shares) | 2013-12-31 | $2,690,511 |
| Administrative expenses professional fees incurred | 2013-12-31 | $22,300 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2013-12-31 | $45,600,422 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2013-12-31 | $25,208,283 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2013-12-31 | $221,251,023 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2013-12-31 | $197,204,053 |
| Other income not declared elsewhere | 2013-12-31 | $-1,882,017 |
| Administrative expenses (other) incurred | 2013-12-31 | $1,917,022 |
| Value of net income/loss | 2013-12-31 | $-6,129,565 |
| Value of net assets at end of year (total assets less liabilities) | 2013-12-31 | $80,772,299 |
| Value of net assets at beginning of year (total assets less liabilities) | 2013-12-31 | $96,902,139 |
| Investment advisory and management fees | 2013-12-31 | $69,293 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2013-12-31 | $81,799,077 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2013-12-31 | $97,235,527 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2013-12-31 | $97,235,527 |
| Income. Dividends from common stock | 2013-12-31 | $2,690,511 |
| Assets. Corporate common stocks other than exployer securities at end of year | 2013-12-31 | $174,623,823 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2013-12-31 | $171,662,382 |
| Aggregate proceeds on sale of assets | 2013-12-31 | $3,151,639,355 |
| Aggregate carrying amount (costs) on sale of assets | 2013-12-31 | $3,159,527,286 |
| 2012 : US SCIENTIFIC ALPHA FUND B 2012 401k financial data |
|---|
| Unrealized appreciation/depreciation of other (non real estate) assets | 2012-12-31 | $-5,615,334 |
| Total unrealized appreciation/depreciation of assets | 2012-12-31 | $-5,615,334 |
| Total transfer of assets to this plan | 2012-12-31 | $12,500,000 |
| Total transfer of assets from this plan | 2012-12-31 | $29,700,275 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2012-12-31 | $197,204,053 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2012-12-31 | $209,577,930 |
| Total income from all sources (including contributions) | 2012-12-31 | $18,248,780 |
| Total loss/gain on sale of assets | 2012-12-31 | $20,900,697 |
| Total of all expenses incurred | 2012-12-31 | $2,871,608 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2012-12-31 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2012-12-31 | $0 |
| Value of total assets at end of year | 2012-12-31 | $294,106,192 |
| Value of total assets at beginning of year | 2012-12-31 | $308,303,172 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2012-12-31 | $2,871,608 |
| Total interest from all sources | 2012-12-31 | $44,202 |
| Total dividends received (eg from common stock, registered investment company shares) | 2012-12-31 | $5,630,677 |
| Administrative expenses professional fees incurred | 2012-12-31 | $20,800 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2012-12-31 | $25,208,283 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2012-12-31 | $37,585,176 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2012-12-31 | $197,204,053 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2012-12-31 | $209,577,930 |
| Other income not declared elsewhere | 2012-12-31 | $-2,711,462 |
| Administrative expenses (other) incurred | 2012-12-31 | $2,789,084 |
| Value of net income/loss | 2012-12-31 | $15,377,172 |
| Value of net assets at end of year (total assets less liabilities) | 2012-12-31 | $96,902,139 |
| Value of net assets at beginning of year (total assets less liabilities) | 2012-12-31 | $98,725,242 |
| Investment advisory and management fees | 2012-12-31 | $61,724 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2012-12-31 | $97,235,527 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2012-12-31 | $99,698,212 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2012-12-31 | $99,698,212 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2012-12-31 | $44,202 |
| Income. Dividends from common stock | 2012-12-31 | $5,630,677 |
| Assets. Corporate common stocks other than exployer securities at end of year | 2012-12-31 | $171,662,382 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2012-12-31 | $171,019,784 |
| Aggregate proceeds on sale of assets | 2012-12-31 | $3,551,651,329 |
| Aggregate carrying amount (costs) on sale of assets | 2012-12-31 | $3,530,750,632 |
| 2011 : US SCIENTIFIC ALPHA FUND B 2011 401k financial data |
|---|
| Unrealized appreciation/depreciation of other (non real estate) assets | 2011-12-31 | $1,189,250 |
| Total unrealized appreciation/depreciation of assets | 2011-12-31 | $1,189,250 |
| Total transfer of assets to this plan | 2011-12-31 | $36,399,400 |
| Total transfer of assets from this plan | 2011-12-31 | $20,000,375 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2011-12-31 | $209,577,930 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2011-12-31 | $234,436,385 |
| Total income from all sources (including contributions) | 2011-12-31 | $18,848,655 |
| Total loss/gain on sale of assets | 2011-12-31 | $17,240,696 |
| Total of all expenses incurred | 2011-12-31 | $3,047,205 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2011-12-31 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2011-12-31 | $0 |
| Value of total assets at end of year | 2011-12-31 | $308,303,172 |
| Value of total assets at beginning of year | 2011-12-31 | $300,961,152 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2011-12-31 | $3,047,205 |
| Total interest from all sources | 2011-12-31 | $205,111 |
| Total dividends received (eg from common stock, registered investment company shares) | 2011-12-31 | $2,267,843 |
| Administrative expenses professional fees incurred | 2011-12-31 | $23,810 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2011-12-31 | $37,585,176 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2011-12-31 | $33,690,722 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2011-12-31 | $209,577,930 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2011-12-31 | $234,436,385 |
| Other income not declared elsewhere | 2011-12-31 | $-2,054,245 |
| Administrative expenses (other) incurred | 2011-12-31 | $2,978,205 |
| Value of net income/loss | 2011-12-31 | $15,801,450 |
| Value of net assets at end of year (total assets less liabilities) | 2011-12-31 | $98,725,242 |
| Value of net assets at beginning of year (total assets less liabilities) | 2011-12-31 | $66,524,767 |
| Investment advisory and management fees | 2011-12-31 | $45,190 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2011-12-31 | $99,698,212 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2011-12-31 | $77,496,208 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2011-12-31 | $77,496,208 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2011-12-31 | $205,111 |
| Income. Dividends from common stock | 2011-12-31 | $2,267,843 |
| Assets. Corporate common stocks other than exployer securities at end of year | 2011-12-31 | $171,019,784 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2011-12-31 | $189,774,222 |
| Aggregate proceeds on sale of assets | 2011-12-31 | $4,026,927,633 |
| Aggregate carrying amount (costs) on sale of assets | 2011-12-31 | $4,009,686,937 |
| 2010 : US SCIENTIFIC ALPHA FUND B 2010 401k financial data |
|---|
| Unrealized appreciation/depreciation of other (non real estate) assets | 2010-12-31 | $-157,170 |
| Total unrealized appreciation/depreciation of assets | 2010-12-31 | $-157,170 |
| Total transfer of assets to this plan | 2010-12-31 | $35,000,000 |
| Total transfer of assets from this plan | 2010-12-31 | $25,000,175 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2010-12-31 | $234,436,385 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2010-12-31 | $147,972,681 |
| Total income from all sources (including contributions) | 2010-12-31 | $8,730,288 |
| Total loss/gain on sale of assets | 2010-12-31 | $8,455,127 |
| Total of all expenses incurred | 2010-12-31 | $1,842,366 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2010-12-31 | $0 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2010-12-31 | $0 |
| Value of total assets at end of year | 2010-12-31 | $300,961,152 |
| Value of total assets at beginning of year | 2010-12-31 | $197,609,701 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2010-12-31 | $1,842,366 |
| Total interest from all sources | 2010-12-31 | $209,912 |
| Total dividends received (eg from common stock, registered investment company shares) | 2010-12-31 | $2,407,562 |
| Administrative expenses professional fees incurred | 2010-12-31 | $23,810 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2010-12-31 | $33,690,722 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2010-12-31 | $45,938,008 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2010-12-31 | $234,436,385 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2010-12-31 | $147,972,681 |
| Other income not declared elsewhere | 2010-12-31 | $-2,185,143 |
| Administrative expenses (other) incurred | 2010-12-31 | $1,771,531 |
| Value of net income/loss | 2010-12-31 | $6,887,922 |
| Value of net assets at end of year (total assets less liabilities) | 2010-12-31 | $66,524,767 |
| Value of net assets at beginning of year (total assets less liabilities) | 2010-12-31 | $49,637,020 |
| Investment advisory and management fees | 2010-12-31 | $47,025 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2010-12-31 | $77,496,208 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2010-12-31 | $50,139,777 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2010-12-31 | $50,139,777 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2010-12-31 | $209,912 |
| Income. Dividends from common stock | 2010-12-31 | $2,407,562 |
| Assets. Corporate common stocks other than exployer securities at end of year | 2010-12-31 | $189,774,222 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2010-12-31 | $101,531,916 |
| Aggregate proceeds on sale of assets | 2010-12-31 | $4,329,485,953 |
| Aggregate carrying amount (costs) on sale of assets | 2010-12-31 | $4,321,030,826 |
